The fusion breakthrough could mean carbon-free power, but not soon. And it’s not going to be like ‘Mr. Fusion’ from ‘Back to the Future II.’
Author: Elizabeth Weise and Karen Weintraub, USA TODAY
Omicron is spreading ‘every place at once,’ experts say. What it could mean for holiday plans.
A group of Massachusetts-based researchers say they believe omicron could already account for about 15% of COVID-19 cases in some parts of the U.S.
Who should get COVID-19 boosters first? CDC committee set to vote Thursday – but only on Pfizer vaccine
Among the more than 20,000 people who have been tracked after receiving a third dose, no major safety concerns have popped up, CDC officials say.
Those fully vaccinated against COVID-19 can be infected, but serious illness is rare: ‘Nothing in this world is 100%’
As many remain unvaccinated and coronavirus cases rise amid the delta variant, some of the vaccinated will get infected, but serious illness is rare.
Vaccine passports should be free, private and secure, White House says. But who will be issuing them?
Israel has a “green card” to prove that people have been vaccinated and other countries are contemplating requiring proof of vaccination for entry.
What does victory against the COVID-19 pandemic look like? USA TODAY’s vaccine panel weighs in
USA TODAY’s panel of experts have different definitions of what the end of the pandemic means. But they agree it’s getting closer.
A COVID-19 vaccine life cycle: from DNA to doses
Making a vaccine against the coronavirus is a complicated, months-long process. Pfizer is working to get it done faster. It still takes time.
Where did COVID-19 come from?
As the U.S. marks one year since its first case, questions remain about the origin of the coronavirus that causes the disease. The answers matter.
Key committee endorses Pfizer’s COVID-19 vaccine, paving way for clearance by FDA and vaccinations in US to begin
The endorsement paves the way for a final decision by the FDA, and mass vaccinations to begin within days.
CDC-convened committee votes to add nursing home residents to first phase of COVID-19 vaccine access
Everyone in Phase 1a should be able to get the first of the two-shot COVID-19 vaccine series within three weeks of one being authorized by the FDA.